Biotech Startups

Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.

1 investor

Innosphere is a technology economic development organization that operates incubators and venture capital programs focused on climate resilience, life sciences, and smart cities, serving early-stage companies and communities across the Mountain Plains region.

1 investor

InnoSyn produces recombinant pig liver esterase enzymes and screening kits for use in organic chemistry applications, particularly for asymmetric synthesis and racemic resolution of chiral compounds. The company supplies these biotech research products to pharmaceutical and chemical synthesis professionals.

1 investor

Innovad Group develops animal health and nutrition products, operating as a primary producer through four manufacturing centers and 18 legal entities worldwide. It serves the animal care industry with platforms, products, and services, and has grown via acquisitions including Scentarom, Herbonis, and Oligobasics.

1 investor

1 investor

Innovcare Lifesciences markets and distributes branded nutraceutical and functional food products to healthcare practitioners across India for managing lifestyle-related disorders. The company operates a pan-India sales network and manufactures products through contract manufacturers meeting international WHO-cGMP standards.

1 investor

Innovis Pharma is a Greek pharmaceutical company founded in 2018 that markets generic, innovative, OTC, and cosmetic products across major therapeutic areas and acts as a commercial partner for other pharmaceutical companies operating in Greece. Since 2023, through its subsidiary Innovis Medical Devices SA, it also commercializes medical devices.

1 investor

Innovita Biological Technology develops rapid point-of-care diagnostic products specializing in infectious disease detection, including multiplex pathogen testing solutions. The company serves clinical and healthcare markets globally with in vitro diagnostic technologies.

1 investor

Inomagen Therapeutics develops a non-viral gene therapy delivered via a single-dose, minimally invasive procedure to target the underlying mechanisms of atrial fibrillation. The company operates under an exclusive license from Northwestern University and is based in a biotech incubator in Chicago.

1 investor

INOPHA GmbH imports, repackages, and distributes parallel-import pharmaceuticals from EU manufacturers—focusing on oncology, rheumatology, growth disorders, and parenteral nutrition—leveraging price differences across EU countries to supply lower-cost original medicines. It serves pharmacies, specialist practices, and hospital pharmacies in Germany.

1 investor

iNova is a pharmaceutical company that develops and markets consumer health products across multiple therapeutic areas including cough, cold, flu, wound care, and pain management. The company focuses on delivering innovative formulations and formats to consumers globally while prioritizing ethical business practices.

1 investor

Inovia Bio is a techbio partner that builds software platforms and provides development, regulatory, and commercial strategy to generate regulatory-grade evidence for drug developers. It serves biotech and pharma clinical development, translational, and medical teams through capabilities including real world evidence and integrated evidence planning.

1 investor

InProcess-LSP manufactures nanoparticle size analyzers for real-time inline monitoring and non-destructive measurements in closed containers, serving pharmaceutical, biotech, and manufacturing companies conducting process development and quality control workflows.

1 investor

Inside Therapeutics develops products and formulation systems for the biotech and pharmaceutical sector, distributed through a global network of scientific-instrument partners. Its product TAMARA is sold internationally via regional distributors across North America, Europe, Asia-Pacific, and South America.

1 investor

InspireMD develops and commercializes medical devices for vascular intervention, including carotid stent systems and embolic protection systems sold through direct sales in the United States and via distributors in international markets.

1 investor

Instance produces large-scale functional biological data intended for AI-driven biology and biological engineering, letting customers submit designs and receive functional data for their specific learning objectives.

1 investor

Instem provides SaaS platforms and services for research and development in the life sciences industry, serving pharmaceutical companies, CROs, CDMOs, academic research institutions, biotechnology firms, industrial organizations, and agrichemical companies.

1 investor

Colorado BioScience Institute is a nonprofit organization focused on developing and diversifying the life sciences workforce in Colorado through education, training, and professional development programs spanning K-12 classrooms to executive-level careers. It serves students, teachers, and professionals via mentorships, partnerships, volunteering, and networking opportunities.

1 investor

Intactis Bio develops a rack-mountable AI accelerator, the Biohybrid Processing Unit (BPU), that combines silicon processors with lab-grown living neurons and a brain-machine interface to run energy-efficient AI/ML data processing. The company positions its biocomputation platform for data centers and high-performance workloads, with applications in AI and drug discovery.

1 investor

Intas is a vertically integrated global pharmaceutical company engaged in formulation development, manufacturing, and marketing of pharmaceuticals across more than 85 countries. The company operates through Accord Healthcare subsidiaries in major markets and invests in biosimilars and new chemical entities.

1 investor

INTA develops the NanoAnalyzer, a portable point-of-care biosensor device that uses a lab-on-chip cartridge and AI-powered nanotech sensors to detect up to six biological analytes from a single blood sample, including biomarkers for traumatic brain injury. The system serves medical, veterinary, food safety, environmental, and industrial diagnostics markets.

1 investor

InTech Medical (operating as EXALTA) provides turnkey OEM manufacturing and engineering solutions for medical devices, primarily serving orthopedic and surgical device companies from concept through regulatory clearance and production launch. The company offers integrated design, regulatory, and manufacturing services with a global footprint.

1 investor

Integrated Biometrics designs and manufactures biometric identification hardware and software, including fingerprint sensors and touchless identification SDKs for law enforcement, border security, government identity systems, and commercial applications across 120+ countries.

1 investor

1 investor